Preprint · OA
via OpenAlex
Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity
Chronis Fatouros, Ghulam Jeelani Pir, Jacek Biernat, Sandhya Padmanabhan Koushika, Eckhard Mandelkow�, Eva‐Maria Mandelkow, Enrico K. Schmidt, Ralf Baumeister
Human Molecular Genetics · 2012 · ▲ 204 citations
Abstract
Increased Tau protein amyloidogenicity has been causatively implicated in several neurodegenerative diseases, collectively called tauopathies. In pathological conditions, Tau becomes hyperphosphorylated and forms intracellular aggregates. The deletion of K280, which is a mutation that commonly appears in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17, enhances Tau aggregation propensity (pro-aggregation). In contrast, introduction of the I277P and I308P mutations prevents β-sheet formation and subsequent aggregation (anti-aggregation). In this study, we created a tauopathy model by expressing pro- or anti-aggregant Tau species in the nervous system of Caenorhabditis elegans. Animals expressing the highly amyloidogenic Tau species showed accelerated Tau aggregation and pathology manifested by severely impaired motility and evident neuronal dysfunction. In addition, we observed that the axonal transport of mitochondria was perturbed in these animals. Control animals expressing the anti-aggregant combination had rather mild phenotype. We subsequently tested several Tau aggregation inhibitor compounds and observed a mitigation of Tau proteotoxicity. In particular, a novel compound that crosses the blood-brain barrier of mammals proved effective in ameliorating the motility as well as delaying the accumulation of neuronal defects. Our study establishes a new C. elegans model of Tau aggregation-mediated toxicity and supports the emerging notion that inhibiting the nucleation of Tau aggregation can be neuroprotective.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/hmg/dds190
- Canonical
- link ↗
- Fetched
- 2026-09-22 MST
Cite this
APA
Fatouros, C., Pir, G.J., Biernat, J., Koushika, S.P., Mandelkow�, E., Mandelkow, E., Schmidt, E.K., & Baumeister, R. (2012). Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. <em>Human Molecular Genetics</em>. https://doi.org/10.1093/hmg/dds190
Vancouver
Fatouros C, Pir GJ, Biernat J, Koushika SP, Mandelkow� E, Mandelkow E, et al. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. Human Molecular Genetics. 2012. doi:10.1093/hmg/dds190.
BibTeX
@unpublished{chronis2012Inhibi,
title = {Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity},
author = {Chronis Fatouros and Ghulam Jeelani Pir and Jacek Biernat and Sandhya Padmanabhan Koushika and Eckhard Mandelkow� and Eva‐Maria Mandelkow and Enrico K. Schmidt and Ralf Baumeister},
journal = {Human Molecular Genetics},
year = {2012},
doi = {10.1093/hmg/dds190},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Reviews Molecular Cell Biology 2023
Preprint · OA
Mechanisms and pathology of protein misfolding and aggregation
Nature Communications 2021
Open access · CC-BY
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
Neuron 2012
Open access · OA
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Preprints.org 2025
Preprint · CC-BY
Protein Aggregation and Proteostasis Failure in Neurodegenerative Diseases: Mechanisms, Structural Insights, and Therapeutic Strategies
Genome Biology and Evolution 2022
Open access · CC-BY
Comparative Study of Protein Aggregation Propensity and Mutation Tolerance Between Naked Mole-Rat and Mouse
Applied Sciences 2025
Open access · CC-BY